Home › Cases › Fungal Sepsis in the Immunocompromised
Neutropenic Sepsis
Fungal Sepsis in the Immunocompromised
6 questions
Question 1 · Fungal sepsis risk
Correct answer: Cryptococcal meningitis — AIDS-defining illness, commonest cause of meningitis in AIDS patients with very low CD4
Why
Cryptococcal meningitis: AIDS-defining illness, most common in CD4 <100. Cryptococcus neoformans — encapsulated fungus. India ink stain of CSF: visible encapsulated budding yeasts. Cryptococcal antigen (CrAg) in CSF and blood — very sensitive. CSF: lymphocytic, raised protein, low glucose.
Key point
Cryptococcal meningitis: CD4 <100, India ink positive, CrAg positive. AIDS-defining. High mortality without treatment.
Question 2 · Cryptococcal treatment
Correct answer: Induction: IV amphotericin B + flucytosine x2 weeks. Consolidation: fluconazole 400mg OD x8 weeks. Maintenance: fluconazole 200mg OD (until CD4 >200 on ART)
Why
Cryptococcal meningitis (IDSA/WHO):
- Induction: IV liposomal amphotericin B + flucytosine — 2 weeks (best regimen)
- Consolidation: fluconazole 400mg — 8 weeks
- Maintenance: fluconazole 200mg daily until CD4 >200 after ART started
ART timing: 4-6 weeks after starting antifungals (IRIS risk if started immediately)
Key point
Cryptococcal: amphotericin + flucytosine (2 weeks) → fluconazole consolidation → maintenance until CD4 >200 on ART.
Question 3 · Raised ICP in cryptococcal
Correct answer: Therapeutic LP (drain CSF to opening pressure <20) to relieve raised ICP. Repeat daily until pressure normalised
Why
Raised ICP in cryptococcal meningitis: very common (obstructed CSF resorption from fungal burden). Management:
- Therapeutic lumbar punctures to drain CSF until opening pressure <20 cmH2O
- Repeat daily if pressure elevated
- Do NOT use dexamethasone (increases fungal burden)
- Shunt rarely needed
Key point
Cryptococcal raised ICP: therapeutic LP (drain to <20). Repeat daily. No dexamethasone — worsens fungal burden.
Question 4 · Candidaemia
Correct answer: IV echinocandin (caspofungin or micafungin) — first line for candidaemia in ICU. Remove or replace central line
Why
Candidaemia: IV echinocandin (caspofungin 70mg loading then 50mg OD, or micafungin) — first line in ICU/moderate-severe. Fluconazole appropriate for stable patients with sensitive Candida. CRITICAL: remove/replace central line — CL is usually the source; persistence without removal leads to treatment failure. Echo to exclude endocarditis.
Key point
Candidaemia: echinocandin (caspofungin) + REMOVE CENTRAL LINE. Echo for endocarditis. Line removal is critical.
Question 5 · Aspergillosis
Correct answer: Invasive pulmonary aspergillosis — halo sign on CT (nodule + surrounding haemorrhagic ground glass) classic for Aspergillus angio-invasion
Why
Invasive aspergillosis: CT 'halo sign' (nodule + surrounding ground glass = angio-invasion with haemorrhage) classic, especially in neutropenic/immunocompromised. Galactomannan antigen positive. Treatment: voriconazole (first line) or isavuconazole. High mortality in immunocompromised.
Key point
Invasive aspergillosis: CT halo sign + galactomannan positive. Voriconazole first line. Immunocompromised risk.
Question 6 · PCP prophylaxis
Correct answer: Continue until CD4 >200 for at least 3 months on ART
Why
PCP prophylaxis stopping: CD4 >200 cells/µL for at least 3 months while on effective ART (undetectable viral load). Co-trimoxazole 960mg OD (or 480mg OD) is primary prophylaxis. Also covers toxoplasmosis. Restart if CD4 <200 again.
Key point
PCP prophylaxis: stop when CD4 >200 sustained for ≥3 months on ART. Restart if CD4 drops below 200.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.